(30 days)
Not Found
Unknown
The description mentions the device "analyzes electrographic signal, classifies all detected heart beats and recognizes rhythm abnormalities," which could potentially involve AI/ML, but the summary does not explicitly state the use of these technologies.
No
The "Intended Use / Indications for Use" section clearly states that the device is for "cardiac monitoring" and "evaluating" or "diagnosing" arrhythmias and their associated symptoms or conditions. It also mentions "monitoring of effect of drugs," which implies observation of treatment, not the treatment itself. The device description also states it "analyzes electrographic signal, classifies all detected heart beats and recognizes rhythm abnormalities," indicating a diagnostic rather than therapeutic function.
Yes
The device description explicitly states it is an "ambulatory ECG monitor which analyzes electrographic signal, classifies all detected heart beats and recognizes rhythm abnormalities." The intended use cases, such as identifying arrhythmias, evaluating syncope, and correlating symptoms with rhythm, are all diagnostic in nature.
No
The device description explicitly states it is an "ambulatory ECG monitor which analyzes electrographic signal," indicating it includes hardware to acquire the ECG signal.
Based on the provided information, the PocketECG III device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the human body (in vitro), such as blood, urine, or tissue. The PocketECG III analyzes the electrographic signal directly from the patient's body (in vivo).
- The device description clearly states it's an "ambulatory ECG monitor which analyzes electrographic signal." This is a direct measurement of electrical activity within the body, not an analysis of a sample taken from the body.
- The intended use and device description focus on monitoring and analyzing the heart's electrical activity. This is a physiological measurement, not a laboratory test on a biological sample.
Therefore, the PocketECG III falls under the category of a medical device that performs physiological monitoring and analysis, but it is not an IVD.
N/A
Intended Use / Indications for Use
The indications for use for the PocketECG III monitor are as follows:
-
- Patients who have a demonstrated need for cardiac monitoring. These may include but are not limited to patients who require monitoring for: a) non-life threatening arrhythmias such as supraventricular tachycardias (e.g. atrial fibrillation, atrial flutter, PACs. PSVT) and ventricular ectopy: b) evaluation of bradyarrhythmias and intermittent bundle branch block, including after cardiovascular surgery and myocardial infarction; and c) arrhythmias associated with co-morbid conditions such as hyperthyroidism or chronic lung disease;
-
- Patients with symptoms that may be due to cardiac arrhythmias. These may include but are not limited to symptoms such as: a) dizziness or lightheadedness; b) syncope of unknown etiology in which arrhythmias are suspected or need to be excluded; and c) dyspnea(shortness of breath);
-
- Patients with palpitations with or without known arrhythmias to obtain correlation of rhythm with symptoms;
-
- Patients who require monitoring of effect of drugs to control ventricular rate in various atrial arrhythmias (e.g. atrial fibrillation);
-
- Patients recovering from cardiac surgery who are indicated for outpatient arrhythmia monitoring;
-
- Patients with diagnosed sleep disordered breathing including sleep apnea (obstructive, central) to evaluate possible nocturnal arrhythmias;
-
- Patients requiring arrhythmia evaluation of etiology of stroke or transient cerebral ischemia, possibly secondary to atrial fibrillation or atrial flutter;
-
- Data from the device may be used by another device to analyze, measure or report QT interval. The device is not intended to sound any alarms for QT interval changes.
Product codes
DSI
Device Description
PocketECG III - Medicalgorithmics Unified Arrhythmia Diagnostic System, type PECGT-IIIV is an ambulatory ECG monitor which analyzes electrographic signal, classifies all detected heart beats and recognizes rhythm abnormalities. All detection results, including annotations for every detected heart beat and the entire ECG signal are transmitted via cellular telephony network to a remote server accessible by a Monitoring Center for reviewing by trained medical staff.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized caduceus or a series of human profiles.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 8, 2015
Medicalgorithmics S.A. % Martin Jasinski Vice President Medicalgorithmics LLC 245 West 107th Street Suite 11 A New York, New York 10025
Re: K152550
Trade/Device Name: PocketECG III - Medicalgorithmics Unified Arrhythmia Diagnostic System, type PECGT-IIIV Regulation Number: 21 CFR 870.1025 Regulation Name: Arrhythmia Detector and Alarm (Including ST-Segment Measurement and Alarm) Regulatory Class: Class II Product Code: DSI Dated: August 5, 2015 Received: September 8, 2015
Dear Martin Jasinski:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR
1
Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Kenneth J. Cavanaugh -S
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known): K152550 Device Name: PocketECG III -Medicalgorithmics Unified Arrhythmia Diagnostic System, type PECGT-IIIV
Indications For Use:
The indications for use for the PocketECG III monitor are as follows:
-
- Patients who have a demonstrated need for cardiac monitoring. These may include but are not limited to patients who require monitoring for: a) non-life threatening arrhythmias such as supraventricular tachycardias (e.g. atrial fibrillation, atrial flutter, PACs. PSVT) and ventricular ectopy: b) evaluation of bradyarrhythmias and intermittent bundle branch block, including after cardiovascular surgery and myocardial infarction; and c) arrhythmias associated with co-morbid conditions such as hyperthyroidism or chronic lung disease;
-
- Patients with symptoms that may be due to cardiac arrhythmias. These may include but are not limited to symptoms such as: a) dizziness or lightheadedness; b) syncope of unknown etiology in which arrhythmias are suspected or need to be excluded; and c) dyspnea(shortness of breath);
-
- Patients with palpitations with or without known arrhythmias to obtain correlation of rhythm with symptoms;
-
- Patients who require monitoring of effect of drugs to control ventricular rate in various atrial arrhythmias (e.g. atrial fibrillation);
-
- Patients recovering from cardiac surgery who are indicated for outpatient arrhythmia monitoring;
-
- Patients with diagnosed sleep disordered breathing including sleep apnea (obstructive, central) to evaluate possible nocturnal arrhythmias;
-
- Patients requiring arrhythmia evaluation of etiology of stroke or transient cerebral ischemia, possibly secondary to atrial fibrillation or atrial flutter;
-
- Data from the device may be used by another device to analyze, measure or report QT interval. The device is not intended to sound any alarms for QT interval changes.
Contradictions:
-
- Patients with potentially life-threatening arrhythmias who require inpatient monitoring;
-
- Patients who the attending physician thinks should be hospitalized.
Prescription Use AND/OR AND/OR AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (CONTINUE ON A SEPARATE PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
3
510(k) Summary
August 4, 2015
| 1. Submitter Name and Address | |
|---|---|
| Medicalgorithmics LLC | 245 West 107th St., Suite 11A |
| New York, NY 10025, USA | |
| Contact Person | Martin Jasinski, phone (917) 9419581, |
| fax (817) 5829527 | |
| 2. Device | |
| Trade name: | PocketECG III – Medicalgorithmics Unified Arrhythmia Diagnostic System |
| Type | PECGT-IIIV |
| Classification name: | Arrhythmia Detector and Alarm |
| Product code: | DSI |
| Regulation no: | 870.1025 |
| Class: | Class II, Special Controls |
3. Substantial Equivalence
The PocketECG III - Medicalgorithmics Unified Arrhythmia Diagnostic System, type PECGT-IIIV is a modification of a legally marked Medicalgorithmics predicate device:
- . PocketECG v3 - Medicalgorithmics Unified Arrhythmia Diagnostic System, type PECGT-III; K124060 (Reg. no. 870.1025)
Note: For commercial reasons Medicalgorithmics S.A. launched the medical device onto the U.S. market under the name of PocketECG III - Medicalgorithmics Unified Arrhythmia Diagnostic System, and has continued to distribute the device under the same name. The modified device is the latest evolution of this predicate one.
4. Device Description
PocketECG III - Medicalgorithmics Unified Arrhythmia Diagnostic System, type PECGT-IIIV is an ambulatory ECG monitor which analyzes electrographic signal, classifies all detected heart beats and recognizes rhythm abnormalities. All detection results, including annotations for every detected heart beat and the entire ECG signal are transmitted via cellular telephony network to a remote server accessible by a Monitoring Center for reviewing by trained medical staff.
5. Indications for Use and contradictions
The indications for use for the PocketECG III, type PECGT-IIIV monitor are as follows:
4
- Patients who have a demonstrated need for cardiac monitoring. These may include but are not limited to patients who require monitoring for: a) non-life threatening arrhythmias such as supraventricular tachycardias (e.g. atrial fibrillation, atrial flutter, PACs, PSVT) and ventricular ectopy; b) evaluation of bradyarrhythmias and intermittent bundle branch block, including after cardiovascular surgery and mvocardial infarction: and c) arrhythmias associated with co-morbid conditions such as hyperthyroidism or chronic lung disease:
-
- Patients with symptoms that may be due to cardiac arrhythmias. These may include but are not limited to symptoms such as: a) dizziness or lightheadedness; b) syncope of unknown etiology in which arrhythmias are suspected or need to be excluded; and c) dyspnea (shortness of breath);
-
- Patients with palpitations with or without known arrhythmias to obtain correlation of rhythm with symptoms;
-
- Patients who require monitoring of effect of drugs to control ventricular rate in various atrial arrhythmias (e.g. atrial fibrillation);
-
- Patients recovering from cardiac surgery who are indicated for outpatient arrhythmia monitoring:
-
- Patients with diagnosed sleep disordered breathing including sleep apnea (obstructive, central) to evaluate possible nocturnal arrhythmias;
-
- Patients requiring arrhythmia evaluation of etiology of stroke or transient cerebral ischemia, possibly secondary to atrial fibrillation or atrial flutter;
-
- Data from the device may be used by another device to analyze, measure or report QT interval. The device is not intended to sound any alarms for OT interval changes.
Contradictions:
-
- Patients with potentially life-threatening arrhythmias who require inpatient monitoring.
-
- Patients who the attending physician thinks should be hospitalized.
6. Predicate Device Information
To K124060 - PocketEG v3 - Medicalgorithmics Unified Arrhythmia Diagnostic System, type PECGT-III
- Similarities:
- o The subject device and the predicate device have the same fundamental scientific technology and intended use:
- o The subject device and the predicate device have the same components: transmitter, lithium-ion rechargeable batteries, AC plug-in battery charger and PC application:
- o The subject device and the predicate device analyze electrographic signal, classify all detected heart beats and recognize rhythm abnormalities:
- o The subject device and the predicate device send all detection results, including annotations for every detected heart beat and the entire ECG signal via cellular telephony network to a remote server;
- Differences: -
5
- The predicate device uses a Global System for Mobile Communication (GSM) o protocol, whereas the subject device uses Code Division Multiple Access protocol (CDMA) for data transmission to a remote server.
7. Referenced standards
The PocketECG III - Medicalgorithmics Unified Arrhythmia Diagnostic System, type PECGT-IIIV meets the requirements of following performance standards in accordance with FDA Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm like the predicate device.
- IEC 60601-1: 2005 + CORR. 1 (2006) + CORR. 2 (2007) "Medical electrical . equipment - Part 1: General requirements for basic safety and essential performance", with National Differences for United States (US) ANSI/AAMI ES 60601-1:2005/A2:2010 "Medical electrical equipment - Part 1: General requirements for basic safety and essential performance",
- IEC 60601-1-2:2007 Medical electrical equipment Part 1-2: General . requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests,
- . IEC 60601-1-11:2010 Medical electrical equipment - Part 1-11: General requirements for basic safety and essential performance - Collateral Standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment,
- IEC 60601-2-47:2012 Medical electrical equipment Part 2-47: Particular . requirements for the basic safety and essential performance of ambulatory electrocardiographic systems.
- . AAMI / ANSI EC57:2012 Testing and Reporting Performance Results of Cardiac Rhythm and ST-Segment Measurement Algorithms.
Quality management system - Medical devices is in conformance with the standards: EN ISO 13485:2012 + EN ISO 13485:2012/AC:2012, ISO 13485:2003 under CMDCAS and EN ISO 9001:2008.
8. Substantial Equivalence Conclusion
PocketECG III - Medicalgorithmics Unified Arrhythmia Diagnostic System, type PECGT-IIIV is safe, effective and substantially equivalent to the predicate device as supported by the descriptive information and the performance testing. The subject device is composed of off-the-shelf, certified devices and components fully complying with the US safety and EMC standards.